Paris, 20 October - Euronext-listed Nortem BioGroup (EPA:MLBIO) (MLBIO.PA), a leader in the European food biotechnology industry, has drafted plans to increasing its production of organic probiotics designed to combat intestinal disorders and treat age-related skin conditions, due to growing consumer demand. The company, already commercializing over 200 products, plants to unroll new probiotic lines in the incoming months under the brand name NaturalPharma Laboratories, and all of them produced
Nortem BioGroup has drafted plans to increasing its production of organic probiotics designed to combat intestinal disorders and treat age-related skin conditions, due to growing consumer demand. The.
Paris, 27 September - Food technology company Nortem BioGroup (EPA:MLBIO) (MLBIO.PA), began trading today on Euronext Paris at a valuation of EUR 12.9.
Paris, 27 September - Food technology company Nortem BioGroup , began trading today on Euronext Paris at a valuation of EUR 12.9 million and a price of EUR 5.00 per share. The company floated.